The Boston Globe

The Boston Globe Names BlueConic a Top Place to Work for 2022

Retrieved on: 
월요일, 12월 5, 2022
Boston.com, Telia Company, Culture, IAC (company), Michelin, RTV Studio B, CDP, STAT, BGMP, Heineken, SVP, Growth, News, Multimedia, Work, Workforce, Professional corporation, A-side and B-side, Online shopping, Architecture, Mattel, The Boston Globe, Globe (tabloid)

KENT, U.K., Dec. 5, 2022 /PRNewswire-PRWeb/ -- BlueConic, the world's leading pure-play customer data platform (CDP), has been named one of the Top Places to Work in Massachusetts in the 15th annual employee-based survey project from The Boston Globe. The Top Places to Work 2022 issue publishes online at Globe.com/TopPlaces on the night of Wednesday, November 30 and in Globe Magazine on Sunday, December 4.

Key Points: 
  • The Top Places to Work 2022 issue publishes online at Globe.com/TopPlaces on the night of Wednesday, November 30 and in Globe Magazine on Sunday, December 4.
  • The survey measures employee opinions about their company's direction, execution, connection, management, work, pay and benefits, and engagement.
  • Having started the year making Built In's Best Place to Work list, it seems only fitting to end the year with our place on Boston Globe's Top Place To Work."
  • BGMP properties include The Boston Globe, Globe Opinion, Globe.com , Boston.com , STAT , The B-Side , Globe Publishing Services, Globe Events , and Studio/B .

Boston Globe Media Launches The B-Side, New Email and Social-Only Product

Retrieved on: 
화요일, 10월 25, 2022
News, B-Sides The Beatles, BGMP, LLC, STAT, The Boston Globe, Twitter, Instagram, RTV Studio B, Multimedia, Health, Boston.com, Social media, University, TikTok, Solution, View, Public relations, Mobile phone

BOSTON, Oct. 25, 2022 /PRNewswire/ -- Boston Globe Media announced today the launch of The B-Side, a new email and social-only product geared towards informing and entertaining new audiences. The B-Side's focus is hyperlocal and will provide curated, authentic and relatable content that reimagines how local news is conveyed to the next generation of Bostonians.

Key Points: 
  • BOSTON, Oct. 25, 2022 /PRNewswire/ -- Boston Globe Media announced today the launch of The B-Side , a new email and social-only product geared towards informing and entertaining new audiences.
  • The B-Side is part of the Boston Globe Media family of brands but is independent from The Boston Globe and Boston.com.
  • About Boston Globe Media Partners, LLC
    Boston Globe Media Partners, LLC ("BGMP") is a multimedia organization that provides news, entertainment, and commentary across multiple brands and platforms.
  • BGMP properties include The Boston Globe, Globe.com , Boston.com , STAT , Globe Publishing Services, Globe Direct, Globe Events , and Studio/B .

Allen & Gerritsen Takes Next Steps To "Protect Our Press," With New Product to Enhance News Literacy

Retrieved on: 
수요일, 10월 12, 2022
A&G, LinkedIn, News, Marketing, Zeta Global, Freedom, Comcast, TJX Companies, The Boston Globe, Association of National Advertisers, Twitter, Instagram, POP, Allen, National Organization for Albinism and Hypopigmentation, Blue Cross Blue Shield Association, Senior, Report, Philadelphia Flyers, Journalism, Democracy, Zeta, Gannett, Industry, Star Tribune, Ad Age, Association, Fourth Estate, Havas Creative, KPI-driven code analysis, Strathcona County, Disability, Public relations, Media, Facebook

BOSTON, Oct. 12, 2022 /PRNewswire-PRWeb/ -- Allen & Gerritsen (A&G), an independent, creative-led advertising agency, today announced the next phase of its signature "Protect Our Press (POP)," initiative launched in 2021 to combat the widespread decrease in local, professional journalism by galvanizing the advertising industry to prioritize and reinvest ad spending with local news outlets.

Key Points: 
  • This Private Marketplace or Inclusion List has been hand-vetted for brand safety, and to ensure that recognizable news outlets are included.
  • A&G conducted further national outreach to encourage publishers to join and become eligible for the additional associated revenue.
  • Allen & Gerritsen (A&G) is an independent, integrated, creative-led agency that is driven by strategy, data and humanity to generate sustainable results for modern brands.
  • A&G was ranked twice by Advertising Age as the #1 "Best Place to Work in Marketing & Media."

Leading White Label UCaaS Provider RingLogix Raises $3M Series A

Retrieved on: 
화요일, 10월 11, 2022
Technology, Other Technology, Telecommunications, Professional Services, Software, Networks, Electronic Design Automation, Consumer Electronics, VoIP, Other Professional Services, Silver Point Capital, Turbocharger, Tehrani, Growth, Managed services, WMAL, Economist, LLC, TMC, Bloomberg Businessweek, APriori Capital Partners, Voice over IP, Los Angeles Times, Technology, Capital, Solution, Software, The Boston Globe, WABC, USA Today, CEO, UC, CGTN, MK Capital, Unified communications as a service, Wonders of the World, USD, Member of the Scottish Parliament, Market share, RT, Bank, Renewable energy, Financial services, The New York Times, Newsweek

Leading white-label UCaaS provider RingLogix received a $3M series A investment from MK Capital to strengthen its position as one of the fastest-growing software companies enabling managed service providers (MSPs) to brand and resell unified communications as a service.

Key Points: 
  • Leading white-label UCaaS provider RingLogix received a $3M series A investment from MK Capital to strengthen its position as one of the fastest-growing software companies enabling managed service providers (MSPs) to brand and resell unified communications as a service.
  • As customers of RingLogix, MSPs can effectively own the UCaaS customer relationship, while simultaneously increasing the profitability and value of their businesses.
  • Albert Diaz, CEO of RingLogix said, This investment represents the next chapter in the RingLogix story.
  • Bret Maxwell, Managing General Partner of MK Capital said, The RingLogix investment was a natural for our firm.

Independent Bank Corp.’s Announcement of Date of Third Quarter Conference Call

Retrieved on: 
금요일, 10월 7, 2022
Banking, Professional Services, Finance, Culture, Rockland Trust, Conference, Internet access, Education, Diversity, Bank, Automated telephone survey, National Association of Affordable Housing Lenders, Shotter v Westpac Banking Corp, Employee resource group, Community, The Boston Globe, Equal housing lender, New England Regional Art Museum, PIN, Inclusion, Community Reinvestment Act, Trust, FDIC, Online shopping

Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company, will host its quarterly conference call to discuss third quarter results on Friday, October 21, 2022, at 10:00 AM Eastern Time.

Key Points: 
  • Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company, will host its quarterly conference call to discuss third quarter results on Friday, October 21, 2022, at 10:00 AM Eastern Time.
  • A replay of the call will be available by calling 877-344-7529, Replay Conference Number: 5395173 which will be available through October 28, 2022.
  • Internet access to the call is available on the Companys website at https://indb.rocklandtrust.com by selecting Third Quarter 2022 Earnings Conference Call.
  • Independent Bank Corp. (NASDAQ Global Select Market: INDB) is the holding company for Rockland Trust Company, a full-service commercial bank headquartered in Massachusetts.

Mersana Therapeutics Announces Completion of Enrollment in UPLIFT, a Single-Arm Registrational Trial of Upifitamab Rilsodotin (UpRi) in Platinum-Resistant Ovarian Cancer

Retrieved on: 
목요일, 10월 6, 2022
Control, U.S. Securities and Exchange Commission, Caregiver, Risk, MRSN, SEC, Therapy, Prevalence, Platinum, NASDAQ, Patient, The Boston Globe, Research, Security (finance), Cancer, Technology, Private Securities Litigation Reform Act, HER2, Food, Food and Drug Administration, Sodium-dependent phosphate transport protein 2B, Incidence, ORR, BLA, Safety, ADC, Bevacizumab, GLOBE, Clinical trial, Maintenance, Forward-looking statement, B7-H4, COVID-19, Ovarian cancer, Fine chemical, Pharmaceutical industry

UpRi is Mersanas first-in-class NaPi2b-targeting ADC with a novel scaffold-linker-payload that enables a high drug-to-antibody ratio and controlled bystander effect.

Key Points: 
  • UpRi is Mersanas first-in-class NaPi2b-targeting ADC with a novel scaffold-linker-payload that enables a high drug-to-antibody ratio and controlled bystander effect.
  • The completion of enrollment in UPLIFT moves us one step closer to our goal of establishing UpRi as a foundational therapy for ovarian cancer, said Anna Protopapas, President and Chief Executive Officer of Mersana Therapeutics.
  • UPLIFT is a single-arm clinical trial evaluating the safety and efficacy of UpRi in patients with platinum-resistant ovarian cancer who have received up to four prior lines of therapy.
  • Mersana Therapeutics was named among the 2021 Top Places to Work in Massachusetts by The Boston Globe.

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
화요일, 10월 4, 2022
RSU, MRSN, Therapy, Platinum, Employment, NASDAQ, Patient, The Boston Globe, Financial compensation, Professional Football Compensation Committee, HER2, Board, Sodium-dependent phosphate transport protein 2B, Safety, ADC, GLOBE, Maintenance, B7-H4, Ovarian cancer, Cancer, Control, Fine chemical

The awards were granted pursuant to terms and conditions fixed by the Compensation Committee and as an inducement material to each new employee entering employment with Mersana in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The awards were granted pursuant to terms and conditions fixed by the Compensation Committee and as an inducement material to each new employee entering employment with Mersana in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The RSUs will vest in four equal annual installments starting November 15, 2023, subject to the applicable employees continued service with Mersana on each such vesting date.
  • Mersana Therapeutics was named among the 2021 Top Places to Work in Massachusetts by The Boston Globe.
  • Mersana routinely posts information that may be useful to investors on the Investors & Media section of its website at www.mersana.com .

Salary.com Secures Significant Equity Investment from Accel-KKR To Help Companies Get Pay Right

Retrieved on: 
화요일, 10월 4, 2022
Culture, Consultant, Super Mario, Software, Accel-KKR, Industry, CEO, The Boston Globe, Boston Business Journal, Growth, Boston, Kenexa, Leadership, Fortune 500, Organization, HCM, Software as a service, Management, Public relations

MENLO PARK, Calif. and WALTHAM, Mass., Oct. 4, 2022 /PRNewswire/ -- Salary.com, the market leader in cloud-based compensation software and data solutions, today announced it has received a significant equity investment from Accel-KKR, a leading technology-focused private equity firm. 

Key Points: 
  • "Pay equity is the defining workplace issue of our time," said Kent Plunkett, co-founder and CEO of Salary.com.
  • Salary.com has remained true to its founding mission to revolutionize how employees and employers manage compensation information and make decisions about what is equitable pay.
  • The company's innovation leadership continues with the recent introduction of the Plunkett Pay Equity Framework and the CompAnalyst Pay Equity Suite , recipient of Ventana Research's 2022 Digital Innovation Award for Human Capital Management.
  • "Pay equity is the defining workplace issue of our time, one that needs to be addressed within the context of an overall compensation strategy," said Kent Plunkett, co-founder and CEO of Salary.com.

Carolyn Pleiss Announced as New Chief Information Officer for Cox Enterprises

Retrieved on: 
금요일, 9월 30, 2022
Adult, VP, Cox, ACP, Acquisition, Compliance, Woman, Cox Communications, The Boston Globe, Program, Autotrader.com, Architecture, Southeastern United States, Cox Automotive, Multimedia, The New York Times, Cox Enterprises, Risk management, Management, Technology

ATLANTA, Sept. 30, 2022 /PRNewswire/ -- Today, Cox Enterprises announced Carolyn Pleiss as its new senior vice president and chief information officer, effective Oct. 2. 

Key Points: 
  • Pleiss was previously Cox Enterprises VP, Strategy and Value Realization
    ATLANTA, Sept. 30, 2022 /PRNewswire/ -- Today, Cox Enterprises announced Carolyn Pleiss as its new senior vice president and chief information officer, effective Oct. 2.
  • "Carolyn has a clear vision of where we need to go as an organization and will help us build on strategies already in place," said Dallas Clement, president and chief financial officer, Cox Enterprises.
  • Pleiss joined Cox AutoTrader Publishing in 2007 before moving to Autotrader.com, where she successfully led its agile transformation.
  • Cox Enterprises is dedicated to building a better future through our leading communications, automotive and media companies.

Mersana Therapeutics Announces Launch of Oncology FACETS, a Resource for Healthcare Providers to Advance Knowledge in Gynecologic Malignancies

Retrieved on: 
금요일, 9월 30, 2022
Control, Safety, MRSN, Movement, Woman, Twitter, ADC, B7-H4, Ohio State University, Ovarian cancer, Virginia Commonwealth University, Biomarker, Health, University of Cincinnati, Clinical Ovarian Cancer & Other Gynecologic Malignancies, FACETS, Sodium-dependent phosphate transport protein 2B, The Boston Globe, Learning, Therapy, HER2, Maintenance, Patient, University, Physician, University of Alabama, Oncology, MBA, Chair, MAS, Committee, Doctor of Philosophy, Grey Literature International Steering Committee, Science, NASDAQ, A Call for Unity, GLOBE, Platinum, University of California, Medicine, MD, New York University

CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company, today announced the launch of Oncology FACETS: an educational platform for healthcare providers that will address clinically impactful topics in gynecologic oncology.

Key Points: 
  • CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company, today announced the launch of Oncology FACETS: an educational platform for healthcare providers that will address clinically impactful topics in gynecologic oncology.
  • Oncology FACETS is driven by a Steering Committee of experts in gynecologic oncology and offers content developed in collaboration with Mersana.
  • We believe Oncology FACETS will provide a valuable resource for physicians seeking to keep pace with this fields rapidly evolving science and data.
  • Biomarkers are central to this movement, and their use in gynecologic malignancies promises to shape the treatment paradigm in the near future.